Notable Analyst Rating Changes 6/9: X, CSX, OMTR, MRVL Higher; HIG, VRX, MAS Lower Jun 9, 2009 09:40AM
Wachovia Downgrades Valeant Pharmaceuticals (VRX) to Underperform; Risk/Reward Unfavorable Jun 9, 2009 08:00AM
Notable Analyst Rating Changes 5/14: PFG, JCI, ANF, CME Upgraded; LPX, AZN, STV Downgraded May 14, 2009 10:06AM